answrsnow
Revenue Operations · Explainer

What's a Good Free Trial Conversion Rate — and How Do You Actually Lift It in 2027?

By Kory White · Updated Oct 2026 · 8 min read
A person working at a laptop on a wooden desk in a bright shared office space
Direct answer

There is no single good number, because the answer depends on whether the trial asks for a card, whether you sell B2B software or a mobile app, and what you divide by. For B2B SaaS, ChartMogul's January 2026 survey of 200 products found a median free-to-paid conversion of 8%, with 4-6% rated good and 10-15% great for no-card trials, and 25-35% good and 50-60% great for trials that require a card. First Page Sage reports 18.2% (opt-in) and 48.8% (opt-out) trial-to-paid for its 86-company data set, a much higher bar that counts a single paid month as a conversion.

For mobile subscription apps, RevenueCat's median app-level trial-to-paid rates run from 39.6% to 46.6% for monthly plans, depending on trial length. To lift your own number, the sources point to five levers: onboarding users to the activation moment, testing trial length, trying a reverse trial, adding sales-assist for product-qualified leads, and testing the pricing page or paywall. Every benchmark here is vendor or survey self-reported, was read on October 31, 2026, and is labelled with who reported it. Treat them as ranges, not targets.

Opt-in versus opt-out: the biggest split in the numbers

An opt-in trial asks for no card; an opt-out trial requires one up front. The two models convert very differently, and the benchmarks disagree about how much, so read each figure with its denominator.

The gap between 4-6% and 18.2% for the same no-card model is not an error. ChartMogul's figures come from a self-reported survey of B2B products at a range of maturity, while First Page Sage reports from its own client data and defines a conversion as even a single paid month. Neither is a census, and both are vendor-reported. Pick the one whose definition matches how you count, and compare like with like.

The card requirement is not free. The ChartMogul report notes it may reduce total signups, and its per-1,000-visitor funnel shows why: a card-required trial gets 35 signups and 10.5 paying customers per 1,000 visitors, while a standard no-card trial gets 45 signups and 3.6 paying. First Page Sage's visitor-to-trial rates tell the same story, at 8.5% for opt-in versus 2.5% for opt-out on organic traffic. A higher conversion rate is a fact about the ratio, not proof that you earn more.

B2B software versus B2C and mobile apps

Most published trial benchmarks are B2B SaaS. The B2C side is best covered by RevenueCat, whose reports draw on its own sample of subscription apps.

Do not hold a B2B product to a mobile-app number. Practitioner reasoning, not sourced data: an app trial usually sits on a store subscription that already has a payment method, so it behaves more like the card-required rows above than a no-card B2B signup. First Page Sage also reports industry spreads for trial-to-paid, from 18.6% for enterprise software to 29.0% for CRM, so even inside B2B the right bar moves.

RevenueCat also compares paywall types at Day 35: a median trial-to-paid of 10.7% for hard paywalls (down from 12.1% in 2025) versus 2.1% for freemium. It is a comparison of apps that pick different models, not a controlled test, so it tells you what the market looks like rather than what your switch would do.

A person's hands resting on a desk beside an open laptop and a notebook with a pencil
Photo: JESHOOTS.COM jeshoots / CC0 via Wikimedia Commons

Trial length: what the data says

ChartMogul's 2026 survey found 14 days is the most common trial length, used by 62% of products, followed by 7 days (14%) and 30 days (14%). Whether a longer trial converts better depends on the data you read.

The honest reading: length is worth an A/B test on your own traffic, not a copy of someone else's default. Mobile data leans longer, the only randomized evidence found here leans flat, and no source read here publishes a B2B conversion rate by trial length.

Lever 1: onboard to the activation moment

Activation is the point where a new user first gets the value you sell. The sources describe tactics rather than controlled results. ChartMogul's March 2026 report lists shortened onboarding, use case-based onboarding, interactive demos and gamified onboarding as what respondents tried, but gives no conversion figures for them.

Userpilot, a vendor, offers two customer examples in its June 2026 article: Kontentino used a welcome survey to route users into persona-specific flows and reported nearly 10% higher activation within the first month, and users who completed Sked Social's four-task checklist converted at 3x the rate of those who skipped it. Both are vendor-selected case studies and the second is a correlation, since motivated users are more likely to finish a checklist.

Practitioner advice, not sourced data: define the single action that best predicts paying, measure how many trial users reach it and when, and fix the biggest drop-off before you touch price or trial length.

Lever 2: test trial length, and whether to ask for a card

Both are cheap to test, and the numbers above show they matter. If you run a no-card trial and have enough traffic, a card-required variant is a test of ratio versus volume: ChartMogul's funnel numbers (35 signups and 10.5 paying versus 45 and 3.6 per 1,000 visitors) show the card trial can win on paying customers, but First Page Sage cautions that a conversion is only a single paid month, so weigh it against retention, churn and lifetime value.

First Page Sage also says newer SaaS businesses are better served by the low barrier of opt-in trials because they need to prove their value. Run any length or card test long enough to measure paid retention, not just first-payment conversion.

Lever 3: try a reverse trial

A reverse trial gives new users time-limited access to paid features, then moves them to a free tier if they do not buy. Kyle Poyar described it in his June 2022 Growth Unhinged newsletter, naming Airtable as an early pioneer.

The evidence is thin. ChartMogul's 2026 report puts reverse trials at 4-6% good and 8-12% great, and finds just 7% of products use one as the primary landing point. Its March report defines the approach but reports no results for it. Poyar's 2022 piece also notes free trial products had 2-3x the free-to-paid conversion rates of freemium products, citing OpenView, with median time-to-purchase of about 14 days versus 60 or 90 days for freemium.

Lever 4: add sales-assist for product-qualified leads

A product-qualified lead (PQL) is a trial user whose in-product behavior suggests they are ready to buy, so a person reaches out at the right moment. ChartMogul reports that 80% of free trial products have human touchpoints when an enterprise user enters the trial, most often customer success (33%) or sales-assist (18%). It does not quantify a lift.

The strongest number is secondhand. Userpilot summarizes a ProductLed survey of 600+ B2B SaaS companies, with the year not stated: free-to-paid averaged 9% across models, while PQL-driven conversion was about 3x that, around 25%, and 30-39% for products with $1k-$5k ACV. Only 24% of companies use PQLs. This compares groups, not a controlled test, and the ProductLed survey itself was not read.

Lever 5: test the pricing page and the paywall

ChartMogul's March 2026 report cites a respondent that added a dual call to action on its homepage, offering either freemium or a 14-day card-required trial, and reported a 26% improvement in creating premium trials. That measures trial creation, not paid conversion, and it is one company's claim.

For apps, RevenueCat's 2026 summary recommends running paywall experiments but does not publish test results. Its data shows 55.4% of cancellations on 3-day trials happen on day 0, and that 46.5% of apps now use trials of 4 days or less, up from 42.1% in 2025. Practitioner advice, not sourced data: change one element at a time, such as the plan shown by default or the trial terms, and judge the test on paid retention.

What a lift is worth

ChartMogul's March 2026 report says 43% of surveyed participants improved free-to-paid conversion over the past 12 months, about one-third of them by 10% to 25% and about one in ten by 25% or more. It also estimates that a 1 percentage point improvement in free-to-paid conversion equates to roughly a 15% increase in new revenue per trial. That is a good argument for working on conversion, but it is a survey of respondents who chose to answer.

Questions people ask

What is a good free trial conversion rate for B2B SaaS?

ChartMogul's January 2026 survey of 200 B2B products found a median free-to-paid rate of 8%. For no-card trials it rates 4-6% good and 10-15% great; for card-required trials, 25-35% good and 50-60% great. First Page Sage reports 18.2% for opt-in and 48.8% for opt-out trials from its own data. All are vendor or survey self-reported.

Is it better to require a credit card for a free trial?

It raises the conversion rate but cuts signups. ChartMogul's funnel shows 35 signups and 10.5 paying per 1,000 visitors for a card-required trial versus 45 signups and 3.6 paying for a standard trial. First Page Sage advises weighing the higher rate against retention and lifetime value.

How long should a free trial be?

The most common length is 14 days, used by 62% of products in ChartMogul's 2026 survey. RevenueCat's mobile data shows monthly plans peaking at 46.6% for 10-16 days, but calls it correlational; a randomized experiment cited by Userpilot found the 7-day trial slightly best with marginal differences. Test it on your own traffic.

What is a good trial conversion rate for a mobile app?

RevenueCat's September 2026 data from 17,000+ apps shows median monthly-plan trial-to-paid of 39.6% to 46.6% depending on trial length, and annual plans of 24% to 44.6%. Those are median app-level figures reported by a vendor.

Do reverse trials convert better than free trials?

Not shown by the sources read here. ChartMogul rates reverse trials 4-6% good and 8-12% great, similar to no-card trials, and reports no results for the tactic. Treat reverse trials as a test, not a proven lift.

Sources

Figures were read from the linked pages on October 31, 2026. Benchmarks are vendor or survey self-reported, use different denominators and years, and are not directly comparable. Where a source gave no number for a tactic, this page says so. Items marked practitioner advice are not sourced data. For a related question, see our freemium pricing page.

Top photo: Crew crew / CC0 via Wikimedia Commons

Share this page
LinkedIn: share linkLinkedIn: share post